Jill DeSimone

Insider Reports History

Entity
Individual
Location
C/O Praxis Precision Medicines, Inc., 99 High Street, 30 Th Floor, Boston, MA
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill DeSimone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Praxis Precision Medicines, Inc. Director Common Stock 14.5K $365K $25.19 Oct 5, 2023 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 24.2K Jun 11, 2024 Direct
Praxis Precision Medicines, Inc. Director Stock Option (Right to Buy) 8.57K Jun 5, 2024 Direct
Oncternal Therapeutics, Inc. Director Stock Options 2.2K Jun 20, 2024 Direct
Kinnate Biopharma Inc. Director Stock Option (right to buy) 0 Apr 3, 2024 Direct

Insider Reports Filed by Jill DeSimone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ONCT Oncternal Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
ITOS iTeos Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
PRAX Praxis Precision Medicines, Inc. Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
KNTE Kinnate Biopharma Inc. Apr 3, 2024 1 $0 4 Apr 5, 2024 Director
ITOS iTeos Therapeutics, Inc. Mar 7, 2024 1 $0 4 Mar 7, 2024 Director
ITOS iTeos Therapeutics, Inc. Mar 7, 2024 0 $0 3 Mar 7, 2024 Director
PRAX Praxis Precision Medicines, Inc. Oct 5, 2023 1 $25.4K 4 Oct 10, 2023 Director
ONCT Oncternal Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
PRAX Praxis Precision Medicines, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
KNTE Kinnate Biopharma Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 Director
KNTE Kinnate Biopharma Inc. Mar 1, 2023 0 $0 3 Mar 3, 2023 Director
ONCT Oncternal Therapeutics, Inc. Jan 4, 2023 1 $0 4 Jan 5, 2023 Director
ONCT Oncternal Therapeutics, Inc. Jan 4, 2023 0 $0 3 Jan 5, 2023 Director
PRAX Praxis Precision Medicines, Inc. May 23, 2022 1 $0 4 May 24, 2022 Director
PRAX Praxis Precision Medicines, Inc. May 23, 2022 0 $0 3 May 24, 2022 Director